Obesity and COVID-19

Парпиева Нургиза Нусратовна, Рахимова Гулнара Нишановна, Тиллашайхова Ирода Мирзогалебовна

Марказий Осиё эндокринологик журнали · 2025-yil

Annotatsiya

Background. Research shows that excess weight negatively affects the development and progression of respiratory diseases. As the SARS-CoV-2 pandemic continues, it is important to understand how body mass index (BMI) affects the manifestation of coronavirus infection. Aim. To study the effect of BMI on the severity of coronavirus infection. Materials and methods of research. The observational, longitudinal, controlled study included 494 patients (311 women, 183 men) aged 18–92 years (mean age ±54.7 years). In accordance with the WHO BMI gradation, all patients were divided into 5 groups Computed tomography (CT) and the intensity of the systemic inflammatory response were used as clinical and laboratory indicators of the severity of COVID-19. Results. Of the 494 patients, more than 70% were overweight (34%) or obese (36.2%). Patients with a body mass index (BMI) greater than 25 kg/m2 had a more severe course of the disease than patients with a lower BMI. This is confirmed by a stronger systemic inflammatory response, more significant changes in chest CT, and a higher risk of admission to the intensive care unit. Conclusion: The risk of developing severe COVID-19 is significantly increased in the presence of overweight and/or obesity.

Maqola ma’lumotlari
MualliflarПарпиева Нургиза Нусратовна, Рахимова Гулнара Нишановна, Тиллашайхова Ирода Мирзогалебовна
JurnalМарказий Осиё эндокринологик журнали
NashriyotРеспублика ихтисослаштирилган эндокринология илмий-амалий тиббиёт маркази
ISSN2181-3426
Nashr sanasi2025-01-24
Jild4
Son3
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-09-06

Maqolaning asl sahifasi

Kalit so‘zlar

Риск развития тяжелого течения COVID-19 значительно повышается при наличии избыточной массы тела и/или ожирения. Ключевые слова: SARS-CoV-2, COVID-19, ожирение, избыточная масса тела, индекс массы тела, SARS-CoV-2, COVID-19, obesity, overweight, body mass index, SARS-CoV-2, COVID-19, семизлик, ортиқча вазн, тана массаси индекси

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAПарпиева Нургиза Нусратовна, Рахимова Гулнара Нишановна, & Тиллашайхова Ирода Мирзогалебовна (2025). OBESITY AND COVID-19. Марказий Осиё эндокринологик журнали, 4(3). https://www.tadqiqot.uz/index.php/cae/article/view/10744
GOST (OAK)Парпиева Нургиза Нусратовна, Рахимова Гулнара Нишановна, Тиллашайхова Ирода Мирзогалебовна OBESITY AND COVID-19 // Марказий Осиё эндокринологик журнали. – 2025. – T. 4, № 3.
MLAПарпиева Нургиза Нусратовна, Рахимова Гулнара Нишановна, and Тиллашайхова Ирода Мирзогалебовна. “OBESITY AND COVID-19.” Марказий Осиё эндокринологик журнали, 4(3), 2025. https://www.tadqiqot.uz/index.php/cae/article/view/10744
ChicagoПарпиева Нургиза Нусратовна, Рахимова Гулнара Нишановна, and Тиллашайхова Ирода Мирзогалебовна. “OBESITY AND COVID-19.” Марказий Осиё эндокринологик журнали, 4(3) (2025). https://www.tadqiqot.uz/index.php/cae/article/view/10744
HarvardПарпиева Нургиза Нусратовна, Рахимова Гулнара Нишановна, and Тиллашайхова Ирода Мирзогалебовна (2025) ‘OBESITY AND COVID-19’, Марказий Осиё эндокринологик журнали, 4(3). https://www.tadqiqot.uz/index.php/cae/article/view/10744
BibTeX
@article{article2025,
  title = {OBESITY AND COVID-19},
  author = {Парпиева Нургиза Нусратовна and Рахимова Гулнара Нишановна and Тиллашайхова Ирода Мирзогалебовна},
  journal = {Марказий Осиё эндокринологик журнали},
  year = {2025},
  volume = {4},
  number = {3},
  url = {https://www.tadqiqot.uz/index.php/cae/article/view/10744}
}

Boshqa maqola uchun iqtibos tayyorlash

Марказий Осиё эндокринологик журнали jurnalidan boshqa maqolalar

Марказий Осиё эндокринологик журнали — barcha maqolalar · 2025-yil arxivi

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari